Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christos-Konstantinos Antoniou , Panagiota Manolakou , Nikolaos Magkas , et al Added: 3 years ago
Cardiac resynchronisation therapy (CRT) has been a cornerstone in the treatment of select advanced heart failure cases since its introduction to our armamentarium in the early 2000s.1 Indeed, 30–60% of advanced heart failure patients exhibit evidence of dyssynchrony, when defined electrocardiographically or mechanically.2–4 The latter is a consequence of the former. CRT has several unique… View more

Heart Failure

Electrophysiology & Arrhythmia
Pharmacological Treatment of Type 2 Diabetes and CVD
Author(s): Felipe Martínez Added: 3 years ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Author(s): Michel Burnier Added: 3 years ago
In 2007, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) published their guidelines for the management of arterial hypertension.1 These guidelines covered in detail all aspects of the management of hypertensive patients, from the diagnosis and detection of early subclinical organ damage to the discussion of the various therapeutic strategies in essential… View more

Standards & Guidelines

Prevention & Chronic Conditions
Author(s): Antoni Martínez-Rubio , Román Freixa Pamias Added: 3 years ago
Hypercholesterolemia has been known for several years to be a major risk factor in the development of atherosclerosis and consecutively cardiovascular disease. This epidemiological concept has been widely confirmed using different strategies that have reduced low-density lipoprotein (LDL) levels and cardiovascular events (morbidity and mortality) in primary as well as in secondary prevention, in… View more

Prevention & Chronic Conditions

Demographic
Author(s): Alberico L Catapano Added: 3 years ago
Introduction Hypercholesterolaemia plays a key role in the development and progression of atherosclerosis and is a proven risk factor for coronary heart disease (CHD).1-4 Therapeutic interventions to lower cholesterol levels both in primary and secondary prevention trials show a clear reduction in the incidence of CHD and stroke.5-11 3-hydroxy-3-methylglutaryl co-enzyme A (HMG-CoA) reductase… View more

Heterogeneous Populations

Prevention & Chronic Conditions
Author(s): Roland E Schmieder Added: 3 years ago
The primary goal in the treatment of hypertensive patients is to achieve the maximum possible reduction in the long-term total risk of cardiovascular (CV) and renal morbidity and mortality. In addition to the lowering of blood pressure (BP) per se, successful realisation of the primary goal of treatment also requires appropriate consideration of co-morbidities.1–3 Although there is some… View more

Prevention & Chronic Conditions
Statin Therapy and the Assessment of Hepatoprotection in Patients with Dyslipidaemia
Author(s): Marinela Beznă , Gabriela Mitoaica , Lorena Ungureanu , et al Added: 11 months ago

Prevention & Chronic Conditions
Author(s): Alberico L Catapano Added: 3 years ago
Introduction Hypercholesterolaemia plays a key role in the development and progression of atherosclerosis and is a proven risk factor for coronary heart disease (CHD).1-4 Therapeutic interventions to lower cholesterol levels both in primary and secondary prevention trials show a clear reduction in the incidence of CHD and stroke.5-11 3-hydroxy-3-methylglutaryl co-enzyme A (HMG-CoA) reductase… View more

Prevention & Chronic Conditions
Dysphagia and the Management of Patients in Need of Lipid-Lowering
Author(s): Yassir Javaid , , Added: 1 year ago
This virtual round table series focuses on dysphagia and the management of patients in need of lipid-lowering medications. The first three sessions of this video series are presented by Dr Yassir Javaid (Northamptonshire CCG, UK), Prof Nina Barnett (London North West University Healthcare NHS Trust, UK) and Mr Paresh Parmar (London North West Healthcare NHS Trust, UK) followed by session four, a… View more

Standards & Guidelines

Prevention & Chronic Conditions
Author(s): Roland RJ van Kimmenade , James L Januzzi Added: 3 years ago
Heart failure (HF) is currently achieving epidemic proportions, representing the single fastest-growing diagnosis among patients aged >65 years of age and the most common cause for hospitalisation in these patients.1 In addition to having a high incidence and prevalence, HF is associated with substandard clinical outcomes and with high rates of hospitalisation and death.1 Accordingly, great… View more

Heart Failure

MI/ACS